Global Molecular Diagnostics Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024

Published - Apr 2019 | Category - Healthcare | No. of Pages - 150 | Published By - EMR


Global Molecular Diagnostics Market was valued at USD 7.5 billion in 2017 and is likely to generate a demand of USD 15.6 billion by 2024, at a vigorous CAGR of 11% over the forecast period.

The growth in the market is attributed to the growing number of infectious diseases and chronic diseases across the globe, improving reimbursement scenario, and increasing adoption of advanced diagnostic techniques. Moreover, the growing increase in collaborative diagnostic programs and increasing investments in diagnostic healthcare is further propelling the industry growth.

Molecular diagnostics play an important role in understanding the pathogenesis of various diseases, as well as in their diagnosis and treatment. The healthcare system is critically and crucially dependent upon diagnostics. Molecular diagnostics has transformed diagnosis dynamically by providing insights into the treatment of various diseases.  Molecular diagnostics market represents a relatively new era in medicine that offers benefits of detecting diseases at an early stage. The major factors driving the growth are increasing incidences of chronic diseases, and the ongoing fight against cancer and other illnesses.

Global Molecular Diagnostics Market Major Manufactures

QIAGEN
HTG Molecular Diagnostics, Inc.
Abbott Laboratories
bioMérieux SA
Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd)
Becton
Dickinson and Company
Hologic Inc.
Cepheid
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.
Genetic Signatures Ltd
Others


 

Quick Buy

Latest Publications